Salem Investment Counselors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$404K Hold
2,126
0.01% 320
2026
Q1
$359K Hold
2,126
0.01% 321
2025
Q4
$359K Buy
2,126
+46
+2% +$7.47K 0.01% 316
2025
Q3
$300K Sell
2,080
-175
-8% -$23.9K 0.01% 330
2025
Q2
$285K Hold
2,255
0.01% 330
2025
Q1
$288K Hold
2,255
0.01% 318
2024
Q4
$298K Hold
2,255
0.01% 316
2024
Q3
$328K Hold
2,255
0.01% 311
2024
Q2
$310K Hold
2,255
0.01% 309
2024
Q1
$309K Buy
2,255
+55
+3% +$7.51K 0.01% 311
2023
Q4
$299K Hold
2,200
0.01% 305
2023
Q3
$269K Buy
+2,200
New +$280K 0.01% 303
2022
Q1
Sell
-50
Closed -$8K 1045
2021
Q4
$8K Sell
50
-75
-60% -$11.6K ﹤0.01% 862
2021
Q3
$20K Hold
125
﹤0.01% 646
2021
Q2
$20K Hold
125
﹤0.01% 624
2021
Q1
$19K Hold
125
﹤0.01% 601
2020
Q4
$19K Hold
125
﹤0.01% 581
2020
Q3
$17K Hold
125
﹤0.01% 514
2020
Q2
$17K Buy
125
+50
+67% +$6.37K ﹤0.01% 506
2020
Q1
$8K Hold
75
﹤0.01% 538
2019
Q4
$9K Sell
75
-1,000
-93% -$112K ﹤0.01% 568
2019
Q3
$107K Hold
1,075
0.01% 292
2019
Q2
$117K Buy
+1,075
New +$114K 0.01% 284
2016
Q4
Sell
-225
Closed -$217 690
2016
Q3
$217 Buy
+225
New +$21.4K ﹤0.01% 373

Other funds holding IBB

Salem Investment Counselors's IBB Position: Q2 2026 in Review

Salem Investment Counselors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,126 shares worth $404K. The position accounts for 0.01% of the portfolio, ranked #320.

Salem Investment Counselors first reported a position in IBB in Q3 2016 and has held it in 24 quarters since. 391 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Salem Investment Counselors held 2,126 shares of iShares Biotechnology ETF worth $404K as of Q2 2026.
  • Salem Investment Counselors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #320 holding.
  • Salem Investment Counselors first reported a position in iShares Biotechnology ETF in Q3 2016 and has held it in 24 quarters since.
  • 391 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.